MENU
+Compare
PYPD
Stock ticker: NASDAQ
AS OF
Sep 5 closing price
Price
$3.45
Change
+$0.05 (+1.47%)
Capitalization
54.85M

PYPD PolyPid Ltd Forecast, Technical & Fundamental Analysis

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology... Show more

PYPD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for PYPD with price predictions
Sep 05, 2025

PYPD in upward trend: price may ascend as a result of having broken its lower Bollinger Band on August 29, 2025

PYPD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 49 cases where PYPD's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 79 cases where PYPD's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for PYPD just turned positive on September 05, 2025. Looking at past instances where PYPD's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PYPD advanced for three days, in of 198 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 27, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on PYPD as a result. In of 120 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

PYPD moved below its 50-day moving average on August 20, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for PYPD crossed bearishly below the 50-day moving average on August 08, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 19 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PYPD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.679) is normal, around the industry mean (20.126). P/E Ratio (0.000) is within average values for comparable stocks, (52.590). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.088). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (327.236).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PYPD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PYPD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
PYPD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

PYPD is expected to report earnings to fall 57.69% to -33 cents per share on November 05

PolyPid Ltd PYPD Stock Earnings Reports
Q3'25
Est.
$-0.33
Q2'25
Missed
by $0.21
Q1'25
Beat
by $0.22
Q4'24
Missed
by $0.22
Q3'24
Missed
by $0.22
The last earnings report on August 13 showed earnings per share of -77 cents, missing the estimate of -56 cents. With 24.88K shares outstanding, the current market capitalization sits at 54.85M.
A.I. Advisor
published General Information

General Information

a clinical stage biopharmaceutical company focusing on the development, manufacture, and commercialization of administered therapies to improve surgical outcomes

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
18 Hasivim Street
Phone
+972 747195700
Employees
62
Web
https://www.polypid.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GDQMF0.500.02
+4.21%
Goldquest Mining Corp.
TKRFF0.05N/A
+2.05%
Tinka Resources Limited
DWHHF24.28N/A
N/A
Deutsche Wohnen SE
PRXXF19.10N/A
N/A
Paradox Interactive AB
WELUF12.19N/A
N/A
Integrated Wellness Acquisition Corp.

PYPD and Stocks

Correlation & Price change

A.I.dvisor tells us that PYPD and ELEV have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PYPD and ELEV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PYPD
1D Price
Change %
PYPD100%
+1.47%
ELEV - PYPD
30%
Poorly correlated
N/A
SER - PYPD
27%
Poorly correlated
-3.60%
PRTA - PYPD
27%
Poorly correlated
+4.14%
SLGL - PYPD
26%
Poorly correlated
-0.14%
CING - PYPD
24%
Poorly correlated
+2.90%
More